Skip to content
Resolve Therapeutics, LLC.
Resolve Therapeutics, LLC.Resolve Therapeutics, LLC.
  • About Us
    • Our Company
    • Management Team
    • SAB
    • Contact Us
  • Pipeline
    • Our Pipeline
  • Science
  • Sjögren’s Clinical Trial
  • Publications
  • News

Follow us on:

Linkedin page opens in new windowFacebook page opens in new window
  • About Us
    • Our Company
    • Management Team
    • SAB
    • Contact Us
  • Pipeline
    • Our Pipeline
  • Science
  • Sjögren’s Clinical Trial
  • Publications
  • News

Daily Archives: November 16, 2016

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

PublicationsBy James PosadaNovember 16, 2016

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

© 2020 Resolve Therapeutics. All rights reserved.

Sitemap   Terms of Use   Privacy Policy  

Go to Top